Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation
Authors
Keywords
-
Journal
Biology-Basel
Volume 10, Issue 9, Pages 874
Publisher
MDPI AG
Online
2021-09-06
DOI
10.3390/biology10090874
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinicopathologic and Molecular Cytogenetic Analysis of 8 Cases With Uterine Cervical Ewing Sarcoma
- (2021) Yufan Cheng et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics
- (2021) C. Christofer Juhlin et al. ENDOCRINE PATHOLOGY
- Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples
- (2021) Katharina Kriegsmann et al. BMC CANCER
- Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
- (2021) C. Christofer Juhlin ENDOCRINE PATHOLOGY
- An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas
- (2021) Sanhong Yu et al. VIRCHOWS ARCHIV
- CD56 expression in basaloid anal squamous cell carcinoma – A potential diagnostic pitfall
- (2021) Sepideh Madahian et al. Annals of Diagnostic Pathology
- Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56
- (2020) Rie Sakakibara et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers: A Comprehensive Study and Review of the Literature
- (2020) Johan Staaf et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A
- (2020) Yunlong Dong et al. Oncology Letters
- Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
- (2020) Carl Christofer Juhlin et al. ENDOCRINE PATHOLOGY
- CD56 is Expressed in Uterine Smooth Muscle Tumors
- (2020) Georgia Karpathiou et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Expression and clinical significance of a new neuroendocrine marker secretagogin in cervical neuroendocrine carcinoma
- (2020) Li Yu et al. JOURNAL OF CLINICAL PATHOLOGY
- Investigation of the Prognostic Significance of Neuroendocrine Differentiation in Gleason Score 7 to 10 Prostate Adenocarcinoma in Patients With Distant Metastasis After Definitive Radiotherapy
- (2020) Nikhil P Mankuzhy et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Immunohistochemistry in Diagnostic Parathyroid Pathology
- (2018) Lori A. Erickson et al. ENDOCRINE PATHOLOGY
- Immunohistochemical Biomarkers in Thyroid Pathology
- (2018) Zubair Baloch et al. ENDOCRINE PATHOLOGY
- INSM1 is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma
- (2018) Mohammed T. Lilo et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections
- (2018) Sanjay Mukhopadhyay et al. MODERN PATHOLOGY
- Neuroendocrine Liver Metastasis—a Specific Set of Markers to Detect Primary Tumor Sites
- (2018) Andreas Selberherr et al. ENDOCRINE PATHOLOGY
- Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame
- (2017) Vincenzo Marotta et al. ENDOCRINE-RELATED CANCER
- A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases
- (2017) Shiho Kuji et al. GYNECOLOGIC ONCOLOGY
- Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation
- (2017) Patricia Mjønes et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms
- (2016) Stefano La Rosa et al. ENDOCRINE PATHOLOGY
- Islet-1 Is a Sensitive But Not Entirely Specific Marker for Pancreatic Neuroendocrine Neoplasms and Their Metastases
- (2013) Rondell P. Graham et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin
- (2013) Abbas Agaimy et al. MODERN PATHOLOGY
- Evaluation of neuroendocrine markers in renal cell carcinoma
- (2010) Hanna Ronkainen et al. Diagnostic Pathology
- Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases
- (2009) Anja M. Schmitt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now